14-23321487-G-GGCGGCA
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM1PP5_Moderate
The NM_004643.4(PABPN1):c.21_26dup(p.Ala10_Ala11dup) variant causes a inframe insertion change. The variant allele was found at a frequency of 0.00000754 in 1,194,274 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: 𝑓 0.000033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000038 ( 0 hom. )
Consequence
PABPN1
NM_004643.4 inframe_insertion
NM_004643.4 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.39
Genes affected
PABPN1 (HGNC:8565): (poly(A) binding protein nuclear 1) This gene encodes an abundant nuclear protein that binds with high affinity to nascent poly(A) tails. The protein is required for progressive and efficient polymerization of poly(A) tails at the 3' ends of eukaryotic transcripts and controls the size of the poly(A) tail to about 250 nt. At steady-state, this protein is localized in the nucleus whereas a different poly(A) binding protein is localized in the cytoplasm. This gene contains a GCG trinucleotide repeat at the 5' end of the coding region, and expansion of this repeat from the normal 6 copies to 8-13 copies leads to autosomal dominant oculopharyngeal muscular dystrophy (OPMD) disease. Related pseudogenes have been identified on chromosomes 19 and X. Read-through transcription also exists between this gene and the neighboring upstream BCL2-like 2 (BCL2L2) gene. [provided by RefSeq, Dec 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM1
In a region_of_interest Disordered (size 114) in uniprot entity PABP2_HUMAN there are 18 pathogenic changes around while only 0 benign (100%) in NM_004643.4
PP5
Variant 14-23321487-G-GGCGGCA is Pathogenic according to our data. Variant chr14-23321487-G-GGCGGCA is described in ClinVar as [Pathogenic]. Clinvar id is 2437738.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PABPN1 | NM_004643.4 | c.21_26dup | p.Ala10_Ala11dup | inframe_insertion | 1/7 | ENST00000216727.9 | NP_004634.1 | |
BCL2L2-PABPN1 | NM_001387343.1 | c.529-691_529-686dup | intron_variant | NP_001374272.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PABPN1 | ENST00000216727.9 | c.21_26dup | p.Ala10_Ala11dup | inframe_insertion | 1/7 | 1 | NM_004643.4 | ENSP00000216727 | P1 | |
PABPN1 | ENST00000397276.6 | c.21_26dup | p.Ala10_Ala11dup | inframe_insertion | 1/6 | 1 | ENSP00000380446 |
Frequencies
GnomAD3 genomes AF: 0.0000331 AC: 5AN: 150908Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
5
AN:
150908
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000383 AC: 4AN: 1043366Hom.: 0 Cov.: 31 AF XY: 0.00000404 AC XY: 2AN XY: 495144
GnomAD4 exome
AF:
AC:
4
AN:
1043366
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
495144
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000331 AC: 5AN: 150908Hom.: 0 Cov.: 32 AF XY: 0.0000271 AC XY: 2AN XY: 73672
GnomAD4 genome
AF:
AC:
5
AN:
150908
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
73672
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Oculopharyngeal muscular dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Aug 08, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at